Cytodyn Inc (CYDY)

[Saltz]

Nader and the major shareholders will take the money and run at anything close to the 4 Billion $ number - $15 per share. To have a chance of getting that number it's going to take stellar Adjunct P3 data combined with strong interim P3 Mono data and AA. Bigger numbers than this have us deeper into 2018 - This all IMO.

The primary investors that raised the money to buy Pro-140 from Progenics in 2012 and put Nader in the power seat showed me the story four years ago - they will jump at 4 Billion / $15. That's a long ways from .70. Let's not get too greedy. I mean with all that has transpired over the last four years and all the hidden land mines even $10 per share sounds really good.

I hope you dreamers are right but I just can't see anything North of $15 unless we are willing to go down the development trail deep into 2018 needing everything go our way. I personally don't want to add an additional year of uncertainty hoping management can get it done - especially in that uncharted territory.